Search results
Results from the WOW.Com Content Network
Impedance cardiography (ICG) is a non-invasive technology measuring total electrical conductivity of the thorax and its changes in time to process continuously a number of cardiodynamic parameters, such as stroke volume (SV), heart rate (HR), cardiac output (CO), ventricular ejection time (VET), pre-ejection period and used to detect the impedance changes caused by a high-frequency, low ...
Indocyanine green (ICG) is a cyanine dye used in medical diagnostics. It is used for determining cardiac output, hepatic function, liver and gastric blood flow, and for ophthalmic and cerebral angiography . [ 4 ]
Bioz was founded by Karin Lachmi and Daniel Levitt. Lachmi is a scientist who completed her postdoc in molecular and cellular biology at the Stanford University School of Medicine. [1] [2] During her lab work she found little available data regarding preferable lab tools, reagents and related products for experimentation. There are 50,000 ...
Indocyanine green (ICG) is a water soluble cyanine dye which shows fluorescence in near-infrared (790–805 nm) range, with peak spectral absorption of 800-810 nm in blood. [1] [2] The near infrared light used in ICGA penetrates ocular pigments such as melanin and xanthophyll, as well as exudates and thin layers of sub-retinal vessels. [3]
In 2022 — the most recent year for which mortality data is available — a total of 941,652 people died of heart disease-related condition
ICG has been a beneficiary of the trend for institutional investors to allocate assets to alternative investments, raising over €10bn during the year ended 31 March 2019. [ 7 ] In November 2022, it was announced ICG had acquired the Madrid -headquartered renewable energy platform, Dos Grados on behalf of its €1.5 billion ($1.56 billion ...
From January 2008 to December 2012, if you bought shares in companies when Ann M. Livermore joined the board, and sold them when she left, you would have a -33.4 percent return on your investment, compared to a -2.8 percent return from the S&P 500.
From January 2008 to December 2012, if you bought shares in companies when Jeffrey O. Henley joined the board, and sold them when he left, you would have a 47.8 percent return on your investment, compared to a -2.8 percent return from the S&P 500.